Cancer and COVID-19: A review of immune insights and partnerships to inform public health strategy
Cancer populations show heterogeneous and often weaker vaccine-induced immunity, highlighting the need for more personalized vaccination strategies. Improving sustained protection requires a deeper understanding of multilayer immune responses and the use of robust, standardized assays that allow reliable comparisons across studies and patient groups.
Authors
- Huijing Xue (ORCID: https://orcid.org/0000-0002-4160-704X)
- Troy J. Kemp
- Lígia A. Pinto (ORCID: https://orcid.org/0000-0002-3130-9882)
- Heidi Hempel (ORCID: https://orcid.org/0000-0003-2830-0593)
- Shweta Jain
- Shin La Shu
Institutions
- Frederick National Laboratory for Cancer Research (US)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1016/j.ijid.2025.108252
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Cancer Institute